US$ 28.26
leading brands of glp-1 agonists in biopharma Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch GLP-1 Receptor Agonist Market Size
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 84.Malbert C-H, Chauvin A, Horowitz M, et al

Available at: (Accessed April, 03, 2024)

Shoppers Drug Mart, Costco, Walmart, and Rexall locations show varying pricing structures across provinces including Ontario, British Columbia, Alberta, and Quebec

This wasnt just a GLP-1 agonist

He added that the drugs effects on the brains emotion and reward pathways also suggest that they may be repurposed to treat other conditions besides obesity, such as substance use disorders
